Art

J-GLOBAL ID：200902237488236654   Reference number：07A0798399

Efficacy and Safety of the Additional Bepridil Treatment in Patients With Atrial Fibrillation Refractory to Class I Antiarrhythmic Drugs

クラスI不整脈剤に難治性の心房細動患者における更なるベプリジル治療の効果および安全性

Author (12)： MIYAJI Kohei (Dep. of Cardiovascular Medicine, Okayama Univ. Graduated School of Medicine, Density and Pharmaceutical Sci.) ,  TADA Hiroshi (Div. of Cardiology, Gunma Prefectural Cardiovascular Center) ,  FUKUSHIMA KUSANO Kengo (Dep. of Cardiovascular Medicine, Okayama Univ. Graduated School of Medicine, Density and Pharmaceutical Sci.) ,  HASHIMOTO Tohru (Div. of Cardiology, Gunma Prefectural Cardiovascular Center) ,  KASENO Kenichi (Div. of Cardiology, Gunma Prefectural Cardiovascular Center) ,  HIRAMATSU Shigeki (Div. of Cardiology, Gunma Prefectural Cardiovascular Center) ,  TADOKORO Kazuyoshi (Div. of Cardiology, Gunma Prefectural Cardiovascular Center) ,  NAITO Shigeto (Div. of Cardiology, Gunma Prefectural Cardiovascular Center) ,  NAKAMURA Kazufumi (Dep. of Cardiovascular Medicine, Okayama Univ. Graduated School of Medicine, Density and Pharmaceutical Sci.) ,  OSHIMA Shigeru (Div. of Cardiology, Gunma Prefectural Cardiovascular Center) ,  TANIGUCHI Koichi (Div. of Cardiology, Gunma Prefectural Cardiovascular Center) ,  OHE Tohru (Dep. of Cardiovascular Medicine, Okayama Univ. Graduated School of Medicine, Density and Pharmaceutical Sci.)
Material： Circulation Journal  (Circ J)
Volume： 71  Issue： 8  Page： 1250-1257 (J-STAGE)  Publication year： 2007 
JST Material Number： F0908A  ISSN： 1346-9843  Document type： Article
Article type： 原著論文  Country of issue： Japan (JPN)  Language： ENGLISH (EN)

Thesaurus term： human(primates) ,...

   To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=07A0798399&from=J-GLOBAL&jstjournalNo=F0908A") }}

JST classification (1)： Drug therapy(=pharmacotherapy)for cardiovascular system diseases  (GJ05020M)

Substance index (1)： Bepridil

Reference (31)：

• 1. Miller JM, Zipes DP. Management of the patient with cardiac arrhythmia. In: Braunwald E, Zipes DP, Libby P, editors. Heart disease, 6th edn. Philadelphia: Saunders; 2001; 700-774.
• 2. Stroobandt R, Stiels B, Hoebrechts R, on behalf of the Propafenone Atrial Fibrillation Trial Investigators. Propafenone for conversion and prophylaxis of atrial fibrillation. Am J Cardiol 1997; 79: 418-423.
• 3. Naccarelli GV, Dorian P, Hohnloser SH, Coumel P. Prospective comparison of flecainide versus quinidine for the treatment of paroxysmal atrial fibrillation/flutter: The Flecainide Multicenter Atrial Fibrillation Study Group. Am J Cardiol 1996; 77: 53A-59A.
• 4. Kuhlkamp V, Schmid F, Risler T, Seipel L. Randomized comparison of flecainide and cibenzoline in the conversion of atrial fibrillation. Int J Cardiol 1991; 31: 65-69.
• 5. Coplen SE, Antman EM, Berlin JA, Hewitt P, Chalmers TC. Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion: A meta-analysis of randomized control trials. Circulation 1990; 82: 1106-1116.

Terms in the title (7)： クラス ,  不整脈 ,  心房細動 ,  患者 ,  ベプリジル ,  治療 ,  安全性